S. Ulrich

Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy

M. Lichtblau, K. Bloch, M. Furian, 2023, European heart journal.

ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

M. Lichtblau, M. Jevnikar, A. Boucly, 2023, ERJ Open Research.

Emergency Care for High-Altitude Trekking and Climbing.

U. Hefti, M. J. van Veelen, M. Philadelphy, 2024, High altitude medicine & biology.

Automated Quantification of QT-Intervals by an Algorithm: A Validation Study in Patients with Chronic Obstructive Pulmonary Disease

K. Bloch, M. Furian, S. Aeschbacher, 2024, International journal of chronic obstructive pulmonary disease.

Altitude illnesses

F. Villafuerte, H. Gatterer, Linda E Keyes, 2024, Nature reviews. Disease primers.

Heart rate variability in pulmonary vascular disease at altitude: a randomised trial

M. Lichtblau, K. Bloch, M. Furian, 2024, ERJ open research.

Symposium review: high altitude travel with pulmonary vascular disease.

M. Lichtblau, S. Schneider, L. Mayer, 2024, The Journal of physiology.

The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial

M. Lichtblau, K. Bloch, M. Furian, 2024, European Respiratory Journal.